Your browser doesn't support javascript.
loading
Arglabin, an EGFR receptor tyrosine kinase inhibitor, suppresses proliferation and induces apoptosis in prostate cancer cells.
El Gaafary, Menna; Morad, Samy A F; Schmiech, Michael; Syrovets, Tatiana; Simmet, Thomas.
Afiliação
  • El Gaafary M; Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University, Ulm D-89081, Germany; Department of Pharmacognosy, College of Pharmacy, Cairo University, Cairo 11562, Egypt.
  • Morad SAF; Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University, Ulm D-89081, Germany; Department of Pharmacology, Faculty of Veterinary Medicine, South Valley University, Qena 83523, Egypt.
  • Schmiech M; Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University, Ulm D-89081, Germany.
  • Syrovets T; Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University, Ulm D-89081, Germany. Electronic address: tatiana.syrovets@uni-ulm.de.
  • Simmet T; Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University, Ulm D-89081, Germany. Electronic address: thomas.simmet@uni-ulm.de.
Biomed Pharmacother ; 156: 113873, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36272260
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Próstata / Neoplasias da Próstata Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Próstata / Neoplasias da Próstata Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article